DOPATREE
Preview
Open in TheBrain
DOPATREE
UNITED STATES GOVERNMENT ORGANIZATIONS / LISTINGS
US FOOD AND DRUG ADMINISTRATION (FDA)
DRUGS AND BIOLOGICS / RELATED / US
DRUG SAFETY AND BIOLOGIC SAFETY (PHARMACOVIGILANCE, PV, CLINICAL, POSTMARKETING, SERIOUS ADVERSE EVENT, SAE, IND, 7-DAY, 15-DAY, EXPEDITED, SIDE EFFECTS, ICSR, PSUR, LITERATURE, SURVEILLANCE, E2B, SAFETY REPORTING, DATA, MEDICATION)
DRUG SAFETY AND BIOLOGIC SAFETY / RELATED / INTL
TREATMENT-RELATED CONDITIONS-ALL (DRUG-RELATED, BIOLOGIC-RELATED, DEVICE-RELATED, TREATMENT EMERGENT ADVERSE EVENTS, TEAE, ADVERSE DRUG REACTIONS, SIDE EFFECTS, ALL TOXICITIES, TOXICITY, PRODUCT-RELATED, DRUG-INDUCED)
TREATMENT-RELATED CONDITIONS / LISTINGS
ELEVATED LIVER FUNCTION TESTS (TRANSAMINASES, LIVER ENZYMES, ALANINE TRANSAMINASE, ALT, ASPARTATE TRANSAMINASE, AST, LIVER DYSFUNCTION)
ELEVATED LIVER FUNCTION TESTS / MITIGATIONS
Parents
ELEVATED LIVER FUNCTION TESTS (TRANSAMINASES, LIVER ENZYMES, ALANINE TRANSAMINASE, ALT, ASPARTATE TRANSAMINASE, AST, LIVER DYSFUNCTION)
Children
INTERRUPT, REDUCE, OR DISCONTINUE TREATMENT DOSE OR RATE DEPENDING ON SEVERITY
MONITOR LIVER ENZYMES AT BASELINE AND DURING TREATMENT